Purepharm Inc.
Records under this name other than the patents Purepharm Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 5 of 5 · Back to Purepharm Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,060,289 | Topical glycopyrrolate product Term ended Term ended May 8, 2022 · From the USPTO record | Term ended | Term ended May 8, 2022 | From the USPTO record |
| US 8,679,524 | Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating Term ended Ended no later than May 8, 2022 · From the USPTO record | Term ended | Ended no later than May 8, 2022 | From the USPTO record |
| US 9,034,368 | Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating Term ended Ended no later than May 8, 2022 · From the USPTO record | Term ended | Ended no later than May 8, 2022 | From the USPTO record |
| US 8,252,316 | Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating Lapsed on the fee record Ended Aug 28, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 28, 2020 | From the USPTO record |
| US 7,448,385 | Nasal adaptation of an oral inhaler device Lapsed on the fee record Ended Nov 11, 2016 · From the USPTO record | Lapsed on the fee record | Ended Nov 11, 2016 | From the USPTO record |